Back to search

Article

Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccination

2023-04-25

Abstract excerpt

<h4>Background</h4> Vaccines have substantially mitigated the disproportional impact of SARS-CoV-2 on the high morbidity and mortality experienced by nursing home residents. However, variation in vaccine efficacy, immune senescence and waning immunity all undermine vaccine effectiveness over time. The introduction of the bivalent vaccine in September 2022 aimed to counter this increasing susceptibility and conseq...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c29c72d5-a6ab-543d-99bc-5bf033a3dd2f
DOI
10.1101/2023.04.25.23289050
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccinationDOI 10.1101/2023.04.25.23289050
Outbreak of SARS-CoV-2 B.1.617.2 (Delta) variant in a Nursing Home 28 weeks after two doses of mRNA anti-Covid-19 vaccines: evidence of a waning immunitySemantic proximity
COVID-19 Booster Doses Reduce Sex Disparities in Antibody Responses among Nursing Home ResidentsSemantic proximity
SARS‐CoV‐2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID‐19 vaccine: Looking for correlates of protectionSemantic proximity
Vaccine-induced correlate of protection against fatal COVID-19 in the old and frail during waves of neutralization resistant variants of concernSemantic proximity
Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workersSemantic proximity
Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adultsSemantic proximity
Anti-nucleocapsid antibody levels following initial and repeat SARS-CoV-2 infections in a cohort of long-term care facility residents in England (VIVALDI)Semantic proximity
Mitigation of imprinted antibody responses against COVID-19 in highly vaccinated older adultsSemantic proximity
Immune and behavioral correlates of protection against symptomatic post-vaccination SARS-CoV-2 infectionSemantic proximity
Health Characteristics Associated With Persistence of SARS-CoV-2 Antibody Responses After Repeated Vaccinations in Older Persons Over Time: The Doetinchem Cohort StudySemantic proximity
Duration of vaccine effectiveness against SARS-CoV2 infection, hospitalisation, and death in residents and staff of Long-Term Care Facilities (VIVALDI): a prospective cohort study, England, Dec 2020-Dec 2021Semantic proximity
Antibody titers before and after booster doses of SARS-CoV-2 mRNA vaccines in healthy adultsSemantic proximity
Select a neighboring publication to make it the new centre.